Clinical Indications for Growth Hormone Therapy

Area of Science:

• Pediatric Endocrinology
• Growth Hormone Therapy
• Genetics

Background:

• Growth hormone (GH) is an injectable medication initially for deficiency, now also for conditions impacting growth.
• Pediatric GH therapy has expanded indications beyond simple deficiency.

Purpose of the Study:

• To characterize growth patterns and GH treatment effects in 8 FDA-approved pediatric indications.
• To guide practitioners on evaluating short stature and initiating GH therapy.
• To review growth patterns warranting specialist referral and safety updates.

Main Methods:

• Review of FDA-approved indications for pediatric GH therapy.
• Characterization of growth patterns and treatment effects for each indication.
• Analysis of growth patterns for specialist referral and safety considerations.

Main Results:

• Identified 8 FDA-approved pediatric indications for GH therapy.
• Detailed growth patterns and effects of GH treatment across these conditions.
• Outlined criteria for referral and updated safety information.

Conclusions:

• GH therapy is indicated for specific pediatric conditions beyond deficiency, including Prader-Willi Syndrome, SGA, idiopathic short stature, Turner syndrome, SHOX haploinsufficiency, Noonan Syndrome, and chronic renal insufficiency.
• Understanding growth patterns and treatment effects is crucial for effective management.
• This review provides a guide for pediatric endocrinologists managing short stature.